Browse
Submit Data
Databases
API
Help

Dataset Information

0 Views

0 Connections

0 Citations

0 Reanalyses

0 Downloads

Omics score: 0

E-GEOD-55193

ABSTRACT: Energy Metabolism during Anchorage-Independence

OTHER RELATED OMICS DATASETS IN: PRJNA238877

PROVIDER: E-GEOD-55193 | ExpressionAtlas | 2019-05-14

REPOSITORIES: ExpressionAtlas

ACCESS DATA

Json Xml

Dataset's files

Source:

			Action	DRS
	E-GEOD-55193-analysis-methods.tsv	Tabular
	E-GEOD-55193-analytics.tsv	Tabular
	E-GEOD-55193-analytics.tsv.undecorated	Tabular
	E-GEOD-55193-analytics.tsv.undecorated.unrounded	Tabular
	E-GEOD-55193-analytics.tsv.unrounded	Tabular

Items per page:

1 - 5 of 51

Similar Datasets

Homo sapiens

Project description:Energy Metabolism during Anchorage-Independence

| PRJNA238877 | ENA

Project description:E.coli Metabolism during Urinary Tract Infection

| PRJEB31942 | ENA

Project description:E.coli metabolism during Urinary Tract Infection

| PRJEB31941 | ENA

Transcription profiling of human hepatocytes treated with doxorubicin and Trovafloxacin, super-series of E-GEOD-11940 and E-GEOD-11941

Project description:This SuperSeries is composed of the following subset Series:; GSE11940: Topoisomerase II inhibition involves characteristic chromosomal expression patterns: Doxorubicin study; GSE11941: Topoisomerase II inhibition involves characteristic chromosomal expression patterns: Trovafloxacin study Experiment Overall Design: Refer to individual Series

2008-10-26 | E-GEOD-11942 | biostudies-arrayexpress

LMO3 reprogramms viseral adipocyte metabolism during obesity

Project description:LMO3 reprogramms viseral adipocyte metabolism during obesity

| PRJNA578670 | ENA

Analysis of pharmacokinetics and pharmacodynamics for capecitabine during new chemotherapy regimen by bevacizumab (Bev) in combination with XELOX in unresectable colorectal cancer

Project description:Interventions: Measurement ofcapecitabin metabolism during XELOX+BV 5-days on/ 2-days off schedule Primary outcome(s): Confirmation for PK/PD analysis of capecitabine Study Design: Single arm Non-randomized

| 2628391 | ecrin-mdr-crc

Longitudinal Assessment of Methylmercury and Gut Microbes During Pregnancy

Project description:<p>Methylmercury is a potent neurotoxin, and the fetal period is the most vulnerable exposure period. There is significant variability in methylmercury metabolism, which has been attributed to differences in the structure and function of the gut microbiome. Our main objective was to better understand the interplay between gut microorganisms and methylmercury metabolism during pregnancy. To address this aim, associations were investigated between maternal biomarkers (blood, hair, stool) for prenatal methylmercury exposure and maternal gut microbiota during early and late gestation.</p>

| phs001768 | dbGaP

Nannochloropsis metabolism during transition from quiescence to autotrophy.

Project description:Nannochloropsis metabolism during transition from quiescence to autotrophy.

| PRJNA530583 | ENA

LMO3 reprogramms viseral adipocyte metabolism during obesity [Human]

Project description:LMO3 reprogramms viseral adipocyte metabolism during obesity [Human]

| PRJNA578664 | ENA

LMO3 reprogramms viseral adipocyte metabolism during obesity [Mouse]

Project description:LMO3 reprogramms viseral adipocyte metabolism during obesity [Mouse]

| PRJNA578677 | ENA